Simon Richardson
Clinician Scientist and Consultant Haematologist | Researches stem cell biology, epigenetics and drug discovery, specialising in B-ALL | Fellow St Catharine's College, Cambridge
@leegrimeslab.bsky.social
🏳️🌈Molecular Oncology 🧬Hematology 🩸and Immunology at Cincinnati Children's Hospital. interested in understanding how ancestry affects cancer genetics and clinical outcomes. https://www.cincinnatichildrens.org/research/divisions/i/immunobiology/labs/grimes
@crukcamcentre.bsky.social
Cancer centre uniting over 1200 experts to tackle cancer from every angle. A partnership between Cancer Research UK, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. crukcambridgecentre.org.uk
@timcoorens.bsky.social
Research Group Leader at EMBL-EBI | Former postdoc at Broad Institute | Former PhD student at Sanger Institute | Lineage tracing, cancer genomics, human development
@thekinglab.bsky.social
Professor in Pediatric Infectious Disease researching effects of infection, inflammation, and the microbiome on hematopoietic stem cells and their progeny. How do infections affect bone marrow and vice versa? Co-Director of BCM MSTP. 🌈
@steidluli.bsky.social
Hematopoiesis, Cancer, and Stem Cell Researcher Professor and Chair, Department of Cell Biology, Albert Einstein College of Medicine Deputy Director, Montefiore Einstein Comprehensive Cancer Center bit.ly/3s3VA1H http://www.steidl-lab.com
@vangalenlab.bsky.social
We integrate cell biology and bioinformatics to study the blood system and identify new strategies to improve human health. Brigham and Women's Hospital, Harvard Medical School, Broad Institute. https://vangalenlab.bwh.harvard.edu
@mullallylab.bsky.social
Heme Chief at Stanford. Physician Scientist studying myeloid malignancies. Views my own.
@coleman-lindsley.bsky.social
Physician-scientist @danafarber.bsky.social studying MDS, AML, and bone marrow failure; Director, Edward P. Evans Center for MDS. lindsleylab.dana-farber.org
@mymkaiser.bsky.social
Haemato-oncologist and myeloma researcher; genetics, imaging and more for patient-centric care. Vice-chair UK NCRI Myeloma Trials. EHA European Affairs. Interested in access and HTA. Academic nomad.
@andrewjohnking.bsky.social
Consultant Haematologist at CUH Transplant, leukaemia, TYA, myeloma, CAR-T
@thedawsonlab.bsky.social
News from the Dawson Lab at Peter MacCallum Cancer Centre Wet and Dry lab scientists interested in circulating tumor DNA and cancer epigenetics
@bloodandtime.bsky.social
Physician-Scientist at Boston Children's/Dana-Farber. Pediatric bone marrow failure, hematopoietic stem cell transplantation, developmental hematopoiesis, disease modeling, pluripotent stem cells.
@boierslab.bsky.social
Dedicated research in Hematology and Leukemia. Focus on B cell Development. Music lover and singer. Views are my own.
@kevinrouault.bsky.social
Reader in SC biology /Group leader at Barts Cancer Institute - QMUL - Centre for Haemato-Onco #Stemcells #MDS #AML #Splicing #ERstress. Opinions are my own.
@hannahuckelmann.bsky.social
Max-Eder junior research group leader studying the epigenetic regulation of stem cell programs in leukemia. #ERC_Research www.uckelmannlab.com
@stjude.bsky.social
@petermaccc.bsky.social
Peter MacCallum Cancer Centre – or Peter Mac – is a globally-connected leader in cancer treatment, care, research and education. Now in its 75th year of providing specialist cancer care for the Australian community.
@jessicaokosun.bsky.social
Professor & Physician Scientist @qmbci.bsky.social. Lymphoma specialist @ Barts Health. Our lab research interests: cancer heterogeneity, somatic evolution, biomarkers, multi-omics, translational lymphoma research
@crick.ac.uk
We're the Crick, a biomedical research lab in London working to figure out how life works. Home to more than 2,000 scientists and a free public exhibition space. https://www.crick.ac.uk/
@robklose.bsky.social
Professor of Genetics Department of Biochemistry University of Oxford kloselab.co.uk
@mgarnett.bsky.social
Cancer programme Faculty @sangerinstitute.bsky.social & founder MosaicTx developing precision combination therapies. #Cancer, Functional genomics, biomarkers, target discovery, #organoid, #CRISPR. Proud 🇨🇦.
@francescoiorio.bsky.social
Research group leader @humantechnopole, cancer researcher, algorithm designer, dad, cook, failed singer, resting runner 😉
@jamie-blundell.bsky.social
Evolution, cancer, immunology, math(s) Ursula Zoellner Professor of Cancer Research University of Cambridge blundelllab.com
@mirjana-efremova.bsky.social
Group leader at the Barts Cancer Institute, investigating non-genetic mechanisms of metastasis and therapy resistance
@landau.bsky.social
Oncologist-scientist at Weill Cornell and New York genome center. Into somatic evolution, trees and words
@campathology.bsky.social
The Department of Pathology at the University of Cambridge
@lisawhittaker02.bsky.social
Research Involvement Lead @ Blood Cancer UK passionate about Patient and Public Involvement & Engagement (PPIE) also do a bit of running 🏴🏴
@carloscaldas1960.bsky.social
Cancer Medicine Physician Scientist @ims-mrl.bsky.social Functional genomics. Breast cancer ecosystems. Cell state and cell fate. Precision Cancer Medicine 2.0 #METABRIC #DETECT #TransNEO #PDTXs @helloeacr.bsky.social
@osinttechnical.bsky.social
PAI enjoyer, OSINT guy @truth.bsky.social , my views/freezing cold takes are my own. Standard spiel about not endorsing retweets, likes, and comments.
@cam.ac.uk
Official account for the University of Cambridge. Follow us for research, news, events and student stories from Cambridge community 🎓📚
@ashakru.bsky.social
Coding Clinician and Postdoc at the Cambridge Stem Cell Institute Researching #lymphoma, #microproteins, #RNA and #ctDNA 🩸🧬 Bye-Fellow, St Catharine's College, Cambridge Likes LOTR 🧙🏼♂️and 35mm film cameras 📷
@istanbullulab.bsky.social
Medicinal chemistry lab @IKCU, Faculty of Pharmacy, Izmir. Drug discovery studies; design and synthesis new compounds as antileishmanial, antibacterial, anticancer, antiparasitic, FABPi, TYK2i @istanbulluh.bsky.social @huseyinkosker.bsky.social
@erc.europa.eu
European Research Council, set up by the EU, funds top researchers of any nationality, helping them pursue great ideas at the frontiers of knowledge. #HorizonEU
@rosslevinemd.bsky.social
Physician Scientist at MSK. All views expressed here are my own & do not represent my employer. COI:http://bit.ly/2LQCLKe
@charlesswanton.bsky.social
Cancer Evolution and Genome Instability Lab Francis Crick Institute. Views my own
@odedrechavi.bsky.social
Epigenetic Inheritance, Neuroscience & anything biology-related https://www.odedrechavilab.com/ TED: https://shorturl.at/myFTY Huberman Lab Podcast: https://youtu.be/CDUetQMKM6g
@tendar.bsky.social
Tyrants are my enemies | Si vis pacem para bellum |🇩🇪🇪🇺| Das Böse triumphiert allein dadurch, dass gute Menschen nichts unternehmen |Military & History
@nocontextbritss.bsky.social
Unofficial. Find the Twitter account here: https://twitter.com/NoContextBrits A celebration of all things great about Britain. Contains sarcasm, irony and some context.
@michiecll.bsky.social
A blood cancer research group based in the Paul O’Gorman Leukaemia Research Centre @pogresearch within the University of Glasgow, studying the biology of chronic lymphocytic leukaemia. 🧪🩸 A proud resident of Glasgow. Views are my own.
@vincentrk.bsky.social
Editor in Chief, Blood Cancer Journal; Professor, Mayo Clinic; Associate Editor, Mayo Clinic Proceedings; Oncologist, Cancer Research, Myeloma.
@alejofraticelli.bsky.social
Aging and cancer stem cell heterogeneity - ICREA research professor - Quantitative Stem Cell Dynamics lab at IRB Barcelona 🇦🇷🇪🇺🇺🇸 fraticellilab.com
@mhairicopland.bsky.social
Professor of Haematology at University of Glasgow. Interests in clinical trials, patients, myeloid disorders, all things CML and stem cells. Views are my own
@natcancer.nature.com
Publishing the latest advances across all areas of cancer research and oncology. Part of @natureportfolio.nature.com 🌐 www.nature.com/natcancer/ 📍New York, London, Berlin and Heidelberg
@ckbrierley.bsky.social
Academic Clinical Lecturer in Haematology, Oxford. Interested in all things myeloid disease and cellular therapy.